IBD patients face increased skin cancer risk

Certain patients with inflammatory bowel disease (IBD) may have an increased risk of skin cancer, which is intensified by the use of immunosuppressant medications , according to two new studies in Gastroenterology, the official journal of the American Gastroenterological Association. Immunosuppressants are commonly used in the treatment of IBD.

In the first study, researchers found that both past and present exposure to thiopurines (a widely used class of immunosuppressants) significantly increased the risk of nonmelanoma (NMSC) in patients with IBD, even before the age of 50. Currently, there are no specific recommendations for screening for skin cancers in individuals with IBD.

"The of skin cancer that we found in our study was observed in all patients, even before the age of 50 years. As expected, this risk increased with age. All patients with currently receiving or having previously received thiopurines should protect their skin from and receive regular dermatologic screening, regardless of their age," said Laurent Peyrin-Biroulet, MD, PhD, of University Hospital of Nancy, Henri Poincaré University, Vandoeuvre-lès-Nancy, France, and lead author of this study.

NMSC mainly encompasses basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), which are by far the most common cancers diagnosed in North America. NMSC continues to be the most common cancer diagnosed among individuals on immunosuppressive medications; patients with IBD are increasingly treated with these immunosuppressant medications.

In a second study, researchers concluded that certain individuals with IBD, such as men with Crohn's disease, may have a baseline increased risk of BCC, and the use of thiopurines increases the risk of SCC.

"All individuals should be protecting themselves against skin cancer," said Harminder Singh, MD, MPH, FRCPC, of the University of Manitoba and lead author of this study. "But, it is especially important that physicians stress the need to be extra vigilant about skin care with their irritable bowel disease patients, especially among those exposed to immunosuppressants such as thiopurines."

However, Dr. Singh and his colleagues note that the small absolute increased risk of NMSC may not merit stopping thiopurines for those who need them for their IBD disease control.

More information: For more information on IBD, please read the AGA brochure "Understanding Inflammatory Bowel Disease" at www.gastro.org/patient-center/digestive-conditions/inflammatory-bowel-disease

add to favorites email to friend print save as pdf

Related Stories

Thiopurine therapy improves quality of life

Mar 01, 2010

Patients with inflammatory bowel diseases (IBDs) such as Crohn's disease or ulcerative colitis do perceive a benefit from thiopurine treatment. A report in the open access journal BMC Gastroenterology has demonstrated improv ...

Recommended for you

US orders farms to report pig virus infections

7 hours ago

The U.S. government is starting a new program to help monitor and possibly control the spread of a virus that has killed millions of pigs since showing up in the country last year.

Foreigner dies of MERS in Saudi

8 hours ago

A foreigner has died after she contracted MERS in the Saudi capital, the health ministry said on announced Friday, bringing the nationwide death toll to 73.

Vietnam battles fatal measles outbreak

11 hours ago

Vietnam is scrambling to contain a deadly outbreak of measles that has killed more than 100 people, mostly young children, and infected thousands more this year, the government said Friday.

New clues on tissue scarring in scleroderma

12 hours ago

A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma.

User comments